Cargando…
TB vaccine development and the End TB Strategy: importance and current status
TB is now the leading, global cause of death due to a single infectious microbe. To achieve the End TB vision of reducing TB by 90% by 2035 we will need new interventions. The objectives of this manuscript are to summarize the status of the clinical TB vaccine pipeline; to assess the challenges faci...
Autores principales: | Fletcher, Helen A., Schrager, Lewis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830404/ https://www.ncbi.nlm.nih.gov/pubmed/27076508 http://dx.doi.org/10.1093/trstmh/trw016 |
Ejemplares similares
-
Drug-resistant TB: deadly, costly and in need of a vaccine
por: Manjelievskaia, Janna, et al.
Publicado: (2016) -
Progress and challenges in TB vaccine development
por: Voss, Gerald, et al.
Publicado: (2018) -
Addressing diabetes mellitus as part of the strategy for ending TB
por: Harries, Anthony D., et al.
Publicado: (2016) -
Towards new TB vaccines
por: Brazier, Benedict, et al.
Publicado: (2020) -
Ending the TB pandemic: the urgency of a new and improved TB vaccine and the World Health Organization's TB Vaccine Accelerator Council
por: Adepoju, Victor Abiola, et al.
Publicado: (2023)